Mairs & Power Inc’s GSK GSK Stock Holding History

Mairs & Power Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-3,077	Closed	-$206K	–	195
2014 Q2	$206K	Sell	3,077 -520	-14%	-$35.2K	﹤0.01%	189
2014 Q1	$240K	Buy	+3,597	New	+$243K	﹤0.01%	185

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mairs & Power Inc's GSK Position: Q3 2014 in Review

Mairs & Power Inc sold out of GSK (GSK) in Q3 2014, closing a stake of 3,077 shares — an estimated $206K sold.

Mairs & Power Inc first reported a position in GSK in Q1 2014 and held it in 2 quarters. The position peaked at $240K in Q1 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

Mairs & Power Inc reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
Mairs & Power Inc sold 3,077 GSK shares in Q3 2014, an estimated $206K.
Mairs & Power Inc first reported a position in GSK in Q1 2014 and held it in 2 quarters.
Mairs & Power Inc's GSK position peaked at $240K in Q1 2014.
701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Mairs & Power Inc's 13F filing for Q3 2014, filed 14 Nov 2014.